Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD
Authors:
- on behalf of the AERIS Study GroupOGon behalf of the AERIS Study Group
- Nicholas P. WilliamsNWNicholas P. Williams
- Kristoffer OstridgeKOKristoffer Ostridge
- Jeanne-Marie DevasterJDJeanne-Marie Devaster
- Viktoriya KimVKViktoriya Kim
- Ngaire A. CoombsNCNgaire A. Coombs
- Simon BourneSBSimon Bourne
- Stuart C. ClarkeSCStuart C. Clarke
- Stephen HardenSHStephen Harden
- Ausami AbbasAAAusami Abbas
- Emmanuel ArisEAEmmanuel Aris
- Christophe LambertCLChristophe Lambert
Open Access
- 28 July 2018
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 19 (1) , 1-12
Abstract
COPD patients have increased risk of developing pneumonia, which is associated with poor outcomes. It can be symptomatically indistinguishable from exacerbations, making diagnosis challenging. Studies of pneumonia in COPD have focused on hospitalised patients and are not representative of the ambulant COPD population. Therefore, we sought to determine the incidence and aetiology of acute exacerbation events with evidence of pneumonic radiographic infiltrates in an outpatient COPD cohort. One hundred twenty-seven patients with moderate to very severe COPD aged 42–85 years underwent blood and sputum sampling over one year, at monthly stable visits and within 72 h of exacerbation symptom onset. 343 exacerbations with chest radiographs were included. 20.1% of exacerbations had pneumonic infiltrates. Presence of infiltrate was highly seasonal (Winter vs summer OR 3.056, p = 0.027). In paired analyses these exacerbation events had greater increases in systemic inflammation. Bacterial detection rate was higher in the pneumonic group, with Haemophilus influenzae the most common bacteria in both radiological groups. Viral detection and sputum microbiota did not differ with chest radiograph appearance. In an outpatient COPD cohort, pneumonic infiltrates at exacerbation were common, and associated with more intense inflammation. Bacterial pathogen detection and lung microbiota were not distinct, suggesting that exacerbations and pneumonia in COPD share common infectious triggers and represent a continuum of severity rather than distinct aetiological events. Trial registration Number: NCT01360398 .Keywords
This publication has 38 references indexed in Scilit:
- Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPDRespiratory Research, 2018
- A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPDThorax, 2017
- Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired PneumoniaClinical Infectious Diseases, 2016
- Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort studyBMJ Open, 2014
- Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort studyBMJ Open, 2014
- Seasonal Distribution of COPD Exacerbations in the Prevention of Exacerbations With Tiotropium in COPD TrialChest, 2013
- Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH studyEuropean Respiratory Journal, 2011
- Bacteria in Exacerbations of Chronic Obstructive Pulmonary Disease: Phenomenon or Epiphenomenon?Proceedings of the American Thoracic Society, 2004
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002